Irritable Bowel Syndrome With Diarrhea
51
2
2
37
Key Insights
Highlights
Success Rate
95% trial completion (above average)
Published Results
12 trials with published results (24%)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
3.9%
2 terminated out of 51 trials
94.9%
+8.4% vs benchmark
25%
13 trials in Phase 3/4
32%
12 of 37 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 37 completed trials
Clinical Trials (51)
Hydrogen Breath Test an Instrument to Predict Rifaximin-Response in Irritable Bowel Syndrome Predominant Diarrhea
Study of the Research Medicine CIN-103 in Adults With Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D).
The Effects of Carbohydrates in Irritable Bowel Syndrome
Effect of Consuming a Nutraceutical Composition on Signs and Symptoms in Adult Patients With Irritable Bowel Syndrome
Comparing the Efficacy of Nitazoxanide Versus Rifaximin in Adult Patients With Irritable Bowel Syndrome Without Constipation
Evaluation of Butyrate and Palmitoylethanolamide in IBS Patients (B/P3_1)
The Effect of Dietary Supplementation on Intestinal Barrier Function in IBS-D
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in IBS
The Role of Fiber in the Prevention and Treatment of Fecal Incontinence
A Study to Evaluate the Efficacy and Safety of Live SK08 Powder in Patients With IBS-D
Safety and Efficacy of a Probiotic Supplement in IBS-D
GI Permeability Change in Response to Aquamin®
B.Subtilis Attenuate Symptoms in Diarrhea-predominant Irritable Bowel Syndrome by Increasing Hypoxanthine Biosynthesis
Efficacy and Safety of Changkang Granule in the Treatment of Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)
Interest of Pan Capsule in Symptomatic Patients Suspected of Irritable Bowel Syndrome Requiring Colonoscopy
Efficacy and Safety of FMT for the Treatment of IBS-D and Mental Health Comorbidity in Young Adults
Faecal Microbiota Transplantation in Irritable Bowel Syndrome
Self- Administered Acupressure for Diarrhea Predominant Irritable Bowel Syndrome
Aldafermin (NGM282) for Chronic Diarrhea Due to Bile Acid Malabsorption (BAM)
Evaluating the Safety and Efficacy of the Probiotic Bifidobacterium Longum ES1 and the Post Biotic Heat-treated Bifidobacterium Longum ES1 (HT-ES1) on IBS Symptom Severity in Patients With Diarrhoea Predominant Irritable Bowel Syndrome